Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co LtdfiledCriticalMochida Pharm Co Ltd
Publication of MY180897ApublicationCriticalpatent/MY180897A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The disclosure provides for a method for treating a fatty liver disease or disorder in a subject in need thereof, comprising selecting a subject having or suspected of having a fatty liver disease or disorder, wherein the subject is non diabetic, pre-diabetic, mildly diabetic; has normal or substantially normal biliary tract function; or has non or early stage hepatocyte apoptosis; and administering a therapeutically effective amount of a pharmaceutical composition comprising EPAs. [No Suitable Fig.]
MYPI2015002248A2013-03-152014-03-14Compositions and methods for treating non-alcoholic steatohepatitis
MY180897A
(en)
Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
method for determining the susceptibility of patients to the development of hypertension, pharmaceutical composition, driving kit, reduction method and patient treatment method